|Title||Eli Lilly I4T-MC-JVDD|
|Principal Investigator/ Physician||Moh’d Khushman, MD|
|Cancer Site||Gastric (Stomach)|
|Contact Email||MCI Clinical Trials|
Protocol Title: "Safety and Effectiveness of Ramucirumab in Patients with Advanced Gastric Cancer in European Union and North America: A prospective Observational Registry."
Inclusion Criteria: Advanced gastric cancer or GEJ adenocarcinoma that has progressed after prior chemotherapy and have initiated Ramucirumab treatment.
Exclusion Criteria: Received more than 1 line of chemotherapy for advanced gastric or GEJ, or currently participating in any other study.
© 2018 USA Health System